{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:09:30Z","timestamp":1778479770281,"version":"3.51.4"},"reference-count":255,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The innate immune sensing system serves as a critical line of defense for recognizing tumor-associated abnormal nucleic acids and initiating antitumor immune responses, and it plays an essential role in lung cancer development, progression, and therapeutic response. Recent studies have shown that, under conditions such as genomic instability, mitochondrial damage, epigenetic dysregulation, and therapy-induced stress, lung cancer cells can release a variety of abnormal DNA, RNA, and damage-associated molecular patterns (DAMPs), thereby activating key innate immune pathways, including cGAS\u2013STING, Toll-like receptor (TLR), and RIG-I-like receptor (RLR) signaling. These pathways regulate the recruitment, activation, and functional differentiation of multiple immune cell populations, including dendritic cells, natural killer cells, neutrophils, macrophages, and T cells, through the induction of type I interferons, inflammatory cytokines, and chemokines, thereby shaping an antitumor immune network in lung cancer. However, during long-term evolution, lung cancer develops multilayered immunosuppressive mechanisms that inhibit innate immune signaling through genetic alterations, epigenetic modifications, ubiquitin-mediated protein degradation, metabolic reprogramming, and non-coding RNA regulation. These processes impair antigen presentation, restrict effector lymphocyte infiltration, and promote the accumulation of immunosuppressive cell populations such as tumor-associated macrophages, myeloid-derived suppressor cells, and regulatory T cells, ultimately leading to immune evasion. This review comprehensively discusses the activation mechanisms of three major innate immune pathways in lung cancer\u2014cGAS\u2013STING, TLR, and RLR signaling\u2014the tumor-mediated negative regulatory mechanisms that suppress them, and their impact on the tumor immune microenvironment. Furthermore, it discusses the potential clinical value of targeting these pathways in immunotherapy, with the aim of providing a theoretical basis for optimizing lung cancer immunotherapeutic strategies and designing combination interventions.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1842558","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:30:02Z","timestamp":1778477402000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Negative regulators antagonizing antitumor innate immune pathways in lung cancer immune evasion"],"prefix":"10.3389","volume":"17","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Oncology, Suining Central Hospital","place":["Suining, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Suining Central Hospital","place":["Suining, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Suining Central Hospital","place":["Suining, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Basic Laboratory Suining Central Hospital","place":["Suining, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Suining Central Hospital","place":["Suining, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer","volume":"359","author":"Herbst","year":"2008","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12943-024-02179-5","article-title":"Current trends in sensitizing immune checkpoint inhibitors for cancer treatment","volume":"23","author":"Wei","year":"2024","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cgas-sting pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"Sting-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gms122","article-title":"Recognition of pathogen-associated nucleic acids by endosomal nucleic acid-sensing toll-like receptors","volume":"45","author":"He","year":"2013","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nature10537","article-title":"Structural basis of RNA recognition and activation by innate immune receptor rig-I","volume":"479","author":"Jiang","year":"2011","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01367-1","article-title":"Genetic immune escape landscape in primary and metastatic cancer","volume":"55","author":"Mart\u00ednez-Jim\u00e9nez","year":"2023","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: Molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transd Targ Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-020-0194-y","article-title":"Noncoding rnas: The shot callers in tumor immune escape","volume":"5","author":"Liu","year":"2020","journal-title":"Signal Transd Targ Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (time) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transd Targ Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01232-z","article-title":"Targeting of tams: Can we be more clever than cancer cells","volume":"21","author":"Kzhyshkowska","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01504-2","article-title":"Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies","volume":"24","author":"Glasner","year":"2023","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110423","article-title":"The cgas-sting pathway in pulmonary diseases: Mechanisms and therapeutic potential","volume":"26","author":"Zhang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cgas-sting pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1579832","article-title":"The activation of cgas-sting pathway offers novel therapeutic opportunities in cancers","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.795401","article-title":"The cgas\/sting\u2002pathway: A novel target for cancer therapy","volume":"12","author":"Gan","year":"2021","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature12306","article-title":"Cgas produces a 2'-5'-linked cyclic dinucleotide second messenger that activates sting","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02283-8","article-title":"Sting signals to nf-\u03bab from late endolysosomal compartments using irf3 as an adaptor","volume":"26","author":"Zhang","year":"2025","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.Cd-19-0761","article-title":"The cytosolic DNA-sensing cgas-sting pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nature23449","article-title":"Cgas surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2103585118","article-title":"Chromatin bridges, not micronuclei, activate cgas after drug-induced mitotic errors in human cells","volume":"118","author":"Flynn","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.010","article-title":"The DNA structure-specific endonuclease mus81 mediates DNA sensor sting-dependent host rejection of prostate cancer cells","volume":"44","author":"Ho","year":"2016","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-021-02120-4","article-title":"Targeting mus81 promotes the anticancer effect of wee1 inhibitor and immune checkpoint blocking combination therapy via activating cgas\/sting signaling in gastric cancer cells","volume":"40","author":"Li","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/jci139333","article-title":"Atm inhibition enhances cancer immunotherapy by promoting mtdna leakage and cgas\/sting activation","volume":"131","author":"Hu","year":"2021","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2419196122","article-title":"The cgas-sting, p38 mapk, and p53 pathways link genome instability to accelerated cellular senescence in atm-deficient murine lung fibroblasts","volume":"122","author":"Haj","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccell.2020.11.004","article-title":"Mlh1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cgas-sting pathway","volume":"39","author":"Guan","year":"2021","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3498","article-title":"Extrachromosomal telomere repeat DNA is linked to alt development via cgas-sting DNA sensing pathway","volume":"24","author":"Chen","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-024-08107-3","article-title":"Origins and impact of extrachromosomal DNA","volume":"635","author":"Bailey","year":"2024","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.31.697191","article-title":"Innate immune sensing via the cgas-sting pathway restricts extrachromosomal DNA-driven tumorigenesis","author":"Li","year":"2026","journal-title":"bioRxiv"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00965-7","article-title":"Molecular mechanisms of mitochondrial DNA release and activation of the cgas-sting pathway","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.05.019","article-title":"Innate immune recognition of mtdna--an undercover signal","volume":"21","author":"Kanneganti","year":"2015","journal-title":"Cell Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899238","article-title":"Mitochondrial inner membrane permeabilization enables mtdna release during apoptosis","volume":"37","author":"Riley","year":"2018","journal-title":"EMBO J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav4011","article-title":"Vdac oligomers form mitochondrial pores to release mtdna fragments and promote lupus-like disease","volume":"366","author":"Kim","year":"2019","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","article-title":"Oxidized DNA fragments exit mitochondria via mptp- and vdac-dependent channels to activate nlrp3 inflammasome and interferon signaling","volume":"55","author":"Xian","year":"2022","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001372","article-title":"Mitochondrial lon-induced mtdna leakage contributes to pd-l1-mediated immunoescape via sting-ifn signaling and extracellular vesicles","volume":"8","author":"Cheng","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.immuni.2017.07.016","article-title":"Dendritic cells but not macrophages sense tumor mitochondrial DNA for cross-priming through signal regulatory protein \u03b1 signaling","volume":"47","author":"Xu","year":"2017","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0456-1","article-title":"Oxidized mitochondrial DNA sensing by sting signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine","volume":"18","author":"Fang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.immuni.2025.03.005","article-title":"Mitochondrial DNA released by senescent tumor cells enhances pmn-mdsc-driven immunosuppression through the cgas-sting pathway","volume":"58","author":"Lai","year":"2025","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsrna including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-21-0506","article-title":"Endogenous retroelements and the viral mimicry response in cancer therapy and cellular homeostasis","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Discov"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.05.005","article-title":"Upregulated line-1 activity in the Fanconi anemia cancer susceptibility syndrome leads to spontaneous pro-inflammatory cytokine production","volume":"8","author":"Br\u00e9gnard","year":"2016","journal-title":"EBioMedicine"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy413","article-title":"Human endogenous retroviruses and their implication for immunotherapeutics of cancer","volume":"29","author":"Attermann","year":"2018","journal-title":"Ann Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/jci164397","article-title":"Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin","volume":"133","author":"Attig","year":"2023","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"Sting-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00894-9","article-title":"Opportunities and challenges of targeting cgas-sting in cancer","volume":"26","author":"Lu","year":"2026","journal-title":"Nat Rev Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cgas-sting signaling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cgas-sting and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.07.009","article-title":"Nsun2 is a glucose sensor suppressing cgas\/sting to maintain tumorigenesis and immunotherapy resistance","volume":"35","author":"Chen","year":"2023","journal-title":"Cell Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113129","article-title":"Stk11\/lkb1 modulation of the immune response in lung cancer: From biology to therapeutic impact","volume":"10","author":"Pons-Tostivint","year":"2021","journal-title":"Cells"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21078","article-title":"Unraveling the role of stk11\/lkb1 in non-small cell lung cancer","volume":"14","author":"Sumbly","year":"2022","journal-title":"Cureus"},{"key":"B63","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1158\/0008-5472.Can-15-1439","article-title":"Stk11\/lkb1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress t-cell activity in the lung tumor microenvironment","volume":"76","author":"Koyama","year":"2016","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12885-023-11343-x","article-title":"Tet2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cgas-sting signaling pathway","volume":"23","author":"Cheng","year":"2023","journal-title":"BMC Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.049","article-title":"Cyclic dinucleotides trigger ulk1 (atg1) phosphorylation of sting to prevent sustained innate immune signaling","volume":"155","author":"Konno","year":"2013","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004783","article-title":"Ppm1a regulates antiviral signaling by antagonizing tbk1-mediated sting phosphorylation and aggregation","volume":"11","author":"Li","year":"2015","journal-title":"PloS Pathog"},{"key":"B67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41421-018-0010-9","article-title":"Trim29 negatively controls antiviral immune response through targeting sting for degradation","volume":"4","author":"Li","year":"2018","journal-title":"Cell Discov"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010157","article-title":"Degradation of parp1 by marchf3 in tumor cells triggers ccas-sting activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma","volume":"12","author":"Cao","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-023-01185-x","article-title":"Sting is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting hk2","volume":"25","author":"Zhang","year":"2023","journal-title":"Nat Cell Biol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cytogfr.2025.06.002","article-title":"Metabolic regulation of cgas-sting signaling in the tumor microenvironment: Dual immune roles and therapeutic implications","volume":"85","author":"Wu","year":"2025","journal-title":"Cytokine Growth Fact Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12964-025-02169-0","article-title":"Unveiling the crossroads of sting signaling pathway and metabolic reprogramming: The multifaceted role of the sting in the tme and new prospects in cancer therapies","volume":"23","author":"Wang","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121646","article-title":"Lactate and lactylation: Dual regulators of t-cell-mediated tumor immunity and immunotherapy","volume":"14","author":"Hao","year":"2024","journal-title":"Biomolecules"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: Mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.984560","article-title":"The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01399","article-title":"Lipid metabolic pathways confer the immunosuppressive function of myeloid-derived suppressor cells in tumor","volume":"10","author":"Yan","year":"2019","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-48026-z","article-title":"Trim29 suppresses Malignant progression in lung squamous cell carcinoma by shaping an immunosuppressive tumor microenvironment","author":"Zhou","year":"2026","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103451","article-title":"Trim29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of e-cadherin","volume":"12","author":"Xu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2174\/1568009623666230829143148","article-title":"Silencing trim29 sensitizes non-small cell lung cancer cells to anlotinib by promoting apoptosis via binding rad50","volume":"24","author":"Wu","year":"2024","journal-title":"Curr Cancer Drug Targets"},{"key":"B79","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41467-017-00101-w","article-title":"Trim29 promotes DNA virus infections by inhibiting innate immune response","volume":"8","author":"Xing","year":"2017","journal-title":"Nat Commun"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/v13040584","article-title":"Negative regulation of the innate immune response through proteasomal degradation and deubiquitination","volume":"13","author":"Budroni","year":"2021","journal-title":"Viruses"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0421-x","article-title":"Decoding type I and iii interferon signaling during viral infection","volume":"4","author":"Mesev","year":"2019","journal-title":"Nat Microbiol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj3945","article-title":"Sting licensing of type I dendritic cells potentiates antitumor immunity","volume":"9","author":"Wang","year":"2024","journal-title":"Sci Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113108","article-title":"Sting signaling promotes nk cell antitumor immunity and maintains a reservoir of tcf-1(+) nk cells","volume":"42","author":"Lu","year":"2023","journal-title":"Cell Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-019-0302-0","article-title":"Sting signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Death Differ"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1470468","article-title":"Bidirectional regulation of the cgas-sting pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molimm.2017.12.001","article-title":"Sting, dcs and the link between innate and adaptive tumor immunity","volume":"110","author":"Vatner","year":"2019","journal-title":"Mol Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00018-024-05191-6","article-title":"Cgas-sting pathway mediates activation of dendritic cell sensing of immunogenic tumors","volume":"81","author":"Li","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.09.065","article-title":"Cancer-cell-intrinsic cgas expression mediates tumor immunogenicity","volume":"29","author":"SChadt","year":"2019","journal-title":"Cell Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.06.014","article-title":"Ccr7 governs skin dendritic cell migration under inflammatory and steady-state conditions","volume":"21","author":"Ohl","year":"2004","journal-title":"Immunity"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of t cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.03.006","article-title":"Dendritic cells prime natural killer cells by trans-presenting interleukin 15","volume":"26","author":"Lucas","year":"2007","journal-title":"Immunity"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-20-1500","article-title":"Met amplification attenuates lung tumor response to immunotherapy by inhibiting sting","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05880-5","article-title":"Sting inhibits the reactivation of dormant metastasis in lung adenocarcinoma","volume":"616","author":"Hu","year":"2023","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by tgf-beta: \"n1\" versus \"n2\" tan","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-844548","article-title":"Neutrophil plasticity in the tumor microenvironment","volume":"133","author":"Giese","year":"2019","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29945","article-title":"Type I ifns induce anti-tumor polarization of tumor associated neutrophils in mice and human","volume":"138","author":"Andzinski","year":"2016","journal-title":"Int J Cancer"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1232221","article-title":"Tumor-associated neutrophils display a distinct n1 profile following tgf\u03b2 modulation: A transcriptomics analysis of pro- vs. antitumor tans","volume":"5","author":"Shaul","year":"2016","journal-title":"Oncoimmunology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12967-023-04446-3","article-title":"Sting signaling activation modulates macrophage polarization via ccl2 in radiation-induced lung injury","volume":"21","author":"Ni","year":"2023","journal-title":"J Transl Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40364-025-00750-w","article-title":"Targeting cgas-sting pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy","volume":"13","author":"Zhang","year":"2025","journal-title":"biomark Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200792","article-title":"Cd47 blockade enhances the efficacy of intratumoral sting-targeting therapy by activating phagocytes","volume":"218","author":"Kosaka","year":"2021","journal-title":"J Exp Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add1153","article-title":"Sting-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy","volume":"8","author":"Wang-Bishop","year":"2023","journal-title":"Sci Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay9013","article-title":"Cgas-sting\u2013mediated DNA sensing maintains cd8+ t cell stemness and promotes antitumor t cell therapy","volume":"12","author":"Li","year":"2020","journal-title":"Sci Transl Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.01.009","article-title":"Sting pathway expression identifies nsclc with an immune-responsive phenotype","volume":"15","author":"Della Corte","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"B105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrc2541","article-title":"Toll-like receptors and cancer","volume":"9","author":"Rakoff-Nahoum","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/nature02761","article-title":"Inferences, questions and possibilities in toll-like receptor signaling","volume":"430","author":"Beutler","year":"2004","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70308","article-title":"Toll-like receptors in the immunotherapy era: Dual-edged swords of tumor immunity and clinical translation","volume":"6","author":"Maihemuti","year":"2025","journal-title":"MedComm (2020)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02388","article-title":"The role of tlrs in anti-cancer immunity and tumor rejection","volume":"10","author":"Urban-Wojciuk","year":"2019","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.012","article-title":"Intracellular toll-like receptors","volume":"32","author":"Blasius","year":"2010","journal-title":"Immunity"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.06.021","article-title":"Tumor exosomal rnas promote lung pre-metastatic niche formation by activating alveolar epithelial tlr3 to recruit neutrophils","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041440","article-title":"Tlr3 expression induces apoptosis in human non-small-cell lung cancer","volume":"21","author":"Bianchi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1172\/jci36551","article-title":"Triggering of tlr7 and tlr8 expressed by human lung cancer cells induces cell survival and chemoresistance","volume":"120","author":"Cherfils-Vicini","year":"2010","journal-title":"J Clin Invest"},{"key":"B115","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.addr.2007.12.004","article-title":"Tlr9 as a key receptor for the recognition of DNA","volume":"60","author":"Kumagai","year":"2008","journal-title":"Adv Drug Delivery Rev"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/s0198-8859(02)00749-8","article-title":"Plasmacytoid dendritic cells: The key to cpg","volume":"63","author":"Rothenfusser","year":"2002","journal-title":"Hum Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1189\/jlb.0807586","article-title":"Heterodimerization of tlr2 with tlr1 or tlr6 expands the ligand spectrum but does not lead to differential signaling","volume":"83","author":"Farhat","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2014.01.015","article-title":"Versican and the control of inflammation","volume":"35","author":"Wight","year":"2014","journal-title":"Matrix Biol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00577","article-title":"Versican and tumor-associated macrophages promotes tumor progression and metastasis in canine and murine models of breast carcinoma","volume":"9","author":"Dos Reis","year":"2019","journal-title":"Front Oncol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-065X.2007.00573.x","article-title":"The interaction between hmgb1 and tlr4 dictates the outcome of anticancer chemotherapy and radiotherapy","volume":"220","author":"Apetoh","year":"2007","journal-title":"Immunol Rev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00456","article-title":"Expression of tlr4 in non-small cell lung cancer is associated with pd-l1 and poor prognosis in patients receiving pulmonectomy","volume":"8","author":"Wang","year":"2017","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-3-030-35582-1_5","article-title":"Toll-like receptors signaling in the tumor microenvironment","volume":"1223","author":"McCall","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: A double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1033483","article-title":"Understanding the role of toll-like receptors in lung cancer immunity and immunotherapy","volume":"13","author":"Hoden","year":"2022","journal-title":"Front Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clim.2008.08.015","article-title":"Gene-specific control of the tlr-induced inflammatory response","volume":"130","author":"Foster","year":"2009","journal-title":"Clin Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.09.008","article-title":"Emerging interleukin-1 receptor-associated kinase 4 (irak4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer","volume":"14","author":"Feng","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1133354","article-title":"Regulation of innate immune signaling by irak proteins","volume":"14","author":"Pereira","year":"2023","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc3911","article-title":"Down-regulation of a20 promotes immune escape of lung adenocarcinomas","volume":"13","author":"Breitenecker","year":"2021","journal-title":"Sci Transl Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0339TR","article-title":"A20 regulation of nuclear factor-\u03bab: Perspectives for inflammatory lung disease","volume":"44","author":"Kelly","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/470468","article-title":"Socs1, a negative regulator of cytokine signals and tlr responses, in human liver diseases","volume":"2010","author":"Fujimoto","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/srep43043","article-title":"Membrane targeting of tirap is negatively regulated by phosphorylation in its phosphoinositide-binding motif","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci Rep"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.697588","article-title":"Tirap in the mechanism of inflammation","volume":"12","author":"Rajpoot","year":"2021","journal-title":"Front Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.09.014","article-title":"Tnfaip3, a negative regulator of the tlr signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder","volume":"59","author":"Hung","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2022.5210","article-title":"Mechanisms and application strategies of mirna-146a regulating inflammation and fibrosis at molecular and cellular levels (review)","volume":"51","author":"Liao","year":"2023","journal-title":"Int J Mol Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1271684","article-title":"Exosomes: Efficient macrophage-related immunomodulators in chronic lung diseases","volume":"12","author":"Kang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.02.074","article-title":"Microrna-21 (mir-21) represses tumor suppressor pten and promotes growth and invasion in non-small cell lung cancer (nsclc)","volume":"411","author":"Zhang","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9902","article-title":"Tlr4\/ros\/mirna-21 pathway underlies lipopolysaccharide instructed primary tumor outgrowth in lung cancer patients","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209414109","article-title":"Micrornas bind to toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155601","article-title":"Mirna-21, an oncomir that regulates cell proliferation, migration, invasion and therapy response in lung cancer","volume":"263","author":"Silvia Lima","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1080\/10799893.2021.2019274","article-title":"Xist\/mir-34a-5p\/pdl1 axis regulated the development of lung cancer cells and the immune function of cd8(+) t cells","volume":"42","author":"Li","year":"2022","journal-title":"J Recept Signal Transd Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23715","article-title":"Downregulation of lncrna mir17hg reduced tumorigenicity and treg-mediated immune escape of non-small-cell lung cancer cells through targeting the mir-17-5p\/runx3 axis","volume":"38","author":"Zheng","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1716180","article-title":"Long non-coding rnas as key orchestrators of the tumor microenvironment in lung cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262412118","article-title":"Integrative analysis of mir-21, pten, and immune signatures in colorectal cancer","volume":"26","author":"Yen","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B147","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-025-07625-6","article-title":"Long non-coding rnas in the tumor immune microenvironment of non-small cell lung cancer: Mechanisms and clinical translational perspectives","volume":"24","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700510","article-title":"Socs1 and socs3 target irf7 degradation to suppress tlr7-mediated type i ifn production of human plasmacytoid dendritic cells","volume":"200","author":"Yu","year":"2018","journal-title":"J Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1236923","article-title":"Irf7: Role and regulation in immunity and autoimmunity","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0808504","article-title":"Tlr7 and tlr8 agonists trigger different signaling pathways for human dendritic cell maturation","volume":"85","author":"Larang\u00e9","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006714","article-title":"Dual tlr9 and pd-l1 targeting unleashes dendritic cells to induce durable antitumor immunity","volume":"11","author":"Fernandez-Rodriguez","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-18-0729","article-title":"Inhaled tlr9 agonist renders lung tumors permissive to pd-1 blockade by promoting optimal cd4(+) and cd8(+) t-cell interplay","volume":"78","author":"Gallotta","year":"2018","journal-title":"Cancer Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.1.138","article-title":"Apc-independent activation of nk cells by the toll-like receptor 3 agonist double-stranded rna","volume":"172","author":"Schmidt","year":"2004","journal-title":"J Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm105","article-title":"Heterogeneity of tlr3 mrna transcripts and responsiveness to poly (i:c) in human nk cells derived from different donors","volume":"19","author":"Sivori","year":"2007","journal-title":"Int Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202300016","article-title":"Hiltonol, a dsrna mimic, promotes nk cell anticancer cytotoxicity through taz cytoplasmic sequestration","volume":"6","author":"Wong","year":"2023","journal-title":"Adv Ther"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxl046","article-title":"Distinct indirect pathways govern human nk-cell activation by tlr-7 and tlr-8 agonists","volume":"18","author":"Gorski","year":"2006","journal-title":"Int Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445132","article-title":"Tlr9 and sting agonists synergistically induce innate and adaptive type-ii ifn","volume":"45","author":"Temizoz","year":"2015","journal-title":"Eur J Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350715","article-title":"Tlr2 on cd4+ and cd8+ t cells promotes control of mycobacterium tuberculosis infection","volume":"54","author":"Reba","year":"2024","journal-title":"Eur J Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93397","article-title":"Combination immunotherapy with tlr agonists and checkpoint inhibitors suppresses head and neck cancer","volume":"2","author":"Sato-Kaneko","year":"2017","journal-title":"JCI Insight"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03315-0","article-title":"Immunotherapy for lung cancer combining the oligodeoxynucleotides of tlr9 agonist and tgf-\u03b22 inhibitor","volume":"72","author":"Yao","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063218","article-title":"Tumor-mediated neutrophil polarization and therapeutic implications","volume":"23","author":"Raftopoulou","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13588","article-title":"Role of tumor-associated neutrophils in lung cancer (review)","volume":"25","author":"Zhou","year":"2023","journal-title":"Oncol Lett"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2024.0192","article-title":"Complex role of neutrophils in the tumor microenvironment: An avenue for novel immunotherapies","volume":"21","author":"Zhang","year":"2024","journal-title":"Cancer Biol Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116671","article-title":"Tlrs in pulmonary diseases","volume":"233","author":"Arora","year":"2019","journal-title":"Life Sci"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009896","article-title":"Cooperative interactions between tlr4 and tlr9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia","volume":"5","author":"Bhan","year":"2010","journal-title":"PloS One"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161512","article-title":"Tlr7\/8 activation in neutrophils impairs immune complex phagocytosis through shedding of fcgriia","volume":"214","author":"Lood","year":"2017","journal-title":"J Exp Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.196.Supp.117.2","article-title":"Tlr8 activation shifts neutrophils from phagocytosis to netosis through furin-dependent shedding of fcgriia","volume":"196","author":"Lood","year":"2016","journal-title":"J Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.009","article-title":"Neutrophils create an impenetrable shield between tumor and cytotoxic immune cells","volume":"52","author":"Ireland","year":"2020","journal-title":"Immunity"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867516","article-title":"Neutrophil extracellular traps (nets) promote non-small cell lung cancer metastasis by suppressing lncrna mir503hg to activate the nf-\u03bab\/nlrp3 inflammasome pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.7150\/thno.111096","article-title":"Targeting neutrophil extracellular traps in cancer progression and metastasis","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00151.2012","article-title":"Hmgb1 promotes neutrophil extracellular trap formation through interactions with toll-like receptor 4","volume":"304","author":"Tadie","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S548334","article-title":"Multifunctional hbc virus-like particles reprogram immunosuppressive macrophages and potentiate cd8(+) t cell responses for enhanced cancer immunotherapy","volume":"20","author":"Liang","year":"2025","journal-title":"Int J Nanomed"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403019","article-title":"Shisa3 reprograms tumor-associated macrophages toward an antitumoral phenotype and enhances cancer immunotherapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004574","article-title":"Targeted repolarization of tumor-associated macrophages via imidazoquinoline-linked nanobodies","volume":"8","author":"Bolli","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1334800","article-title":"Polymeric nanocapsules loaded with poly(i:c) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors","volume":"14","author":"Anfray","year":"2023","journal-title":"Front Immunol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002408","article-title":"Intratumoral combination therapy with poly(i:c) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity","volume":"9","author":"Anfray","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1172\/jci129679","article-title":"Seh promotes macrophage phagocytosis and lung clearance of streptococcus pneumoniae","volume":"131","author":"Li","year":"2021","journal-title":"J Clin Invest"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0288-3","article-title":"Rig-i-like receptors: Their regulation and roles in rna sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.039","article-title":"Structural basis for the activation of innate immune pattern-recognition receptor rig-i by viral rna","volume":"147","author":"Kowalinski","year":"2011","journal-title":"Cell"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2010.07.002","article-title":"Rig-i \"sees\" the 5'-triphosphate","volume":"18","author":"Zheng","year":"2010","journal-title":"Structure"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/s41467-018-04214-8","article-title":"Molecular mechanism of influenza a ns1-mediated trim25 recognition and inhibition","volume":"9","author":"Koliopoulos","year":"2018","journal-title":"Nat Commun"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2019.03.017","article-title":"Ubiquitin-dependent and -independent roles of e3 ligase riplet in innate immunity","volume":"177","author":"Cadena","year":"2019","journal-title":"Cell"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01489","article-title":"Structural basis for the prion-like mavs filaments in antiviral innate immunity","volume":"3","author":"Xu","year":"2014","journal-title":"Elife"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.018","article-title":"A prion-like trigger of antiviral signaling","volume":"146","author":"Ye","year":"2011","journal-title":"Cell"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.103877","article-title":"Exploring viral mimicry combined with epigenetics and tumor immunity: New perspectives in cancer therapy","volume":"21","author":"Wang","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-023-00290-w","article-title":"Expression of down-regulated erv ltr elements associates with immune activation in human small-cell lung cancers","volume":"14","author":"Russo","year":"2023","journal-title":"Mob DNA"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218071","article-title":"Loss of adar1 in lung cancer activates anti-tumor immunity and suppresses tumor cell growth via the rig-i\/mda5-mavs pathway","volume":"635","author":"Jia","year":"2025","journal-title":"Cancer Lett"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0363-0","article-title":"Mitochondrial double-stranded rna triggers antiviral signaling in humans","volume":"560","author":"Dhir","year":"2018","journal-title":"Nature"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302396","article-title":"Trafficking of mitochondrial double-stranded rna from mitochondria to the cytosol","volume":"7","author":"Krieger","year":"2024","journal-title":"Life Sci Allianc"},{"key":"B191","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cell.2017.06.031","article-title":"Exosome rna unshielding couples stromal activation to pattern recognition receptor signaling in cancer","volume":"170","author":"Nabet","year":"2017","journal-title":"Cell"},{"key":"B192","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","article-title":"Circndufb2 inhibits non-small cell lung cancer progression via destabilizing igf2bps and activating anti-tumor immunity","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.06.015","article-title":"Rna polymerase iii detects cytosolic dna and induces type i interferons through the rig-i pathway","volume":"138","author":"Chiu","year":"2009","journal-title":"Cell"},{"key":"B194","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s42003-023-05080-x","article-title":"Transposable elements potentiate radiotherapy-induced cellular immune reactions via rig-i-mediated virus-sensing pathways","volume":"6","author":"Du","year":"2023","journal-title":"Commun Biol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168824","article-title":"Potentiating the radiation-induced type i interferon antitumoral immune response by atm inhibition in pancreatic cancer","volume":"9","author":"Zhang","year":"2024","journal-title":"JCI Insight"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646484","article-title":"Negative regulators of the rig-i-like receptor signaling pathway","volume":"47","author":"Quicke","year":"2017","journal-title":"Eur J Immunol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3390\/v13020182","article-title":"Viral evasion of rig-i-like receptor-mediated immunity through dysregulation of ubiquitination and isgylation","volume":"13","author":"Chiang","year":"2021","journal-title":"Viruses"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1604277113","article-title":"Rnf122 suppresses antiviral type i interferon production by targeting rig-i cards to mediate rig-i degradation","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01376-5","article-title":"The e3 ligase asb3 downregulates antiviral innate immunity by targeting mavs for ubiquitin-proteasomal degradation","volume":"31","author":"Cheng","year":"2024","journal-title":"Cell Death Differ"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611551104","article-title":"Negative regulation of the Rig-I signaling by the ubiquitin ligase Rnf125","volume":"104","author":"Arimoto","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.01.011","article-title":"Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting Rig-I degradation","volume":"152","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"B202","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2019.05.003","article-title":"Lactate is a natural suppressor of RLR signaling by targeting MAVS","volume":"178","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1227041","article-title":"Retinoic acid-inducible gene-I like receptor pathway in cancer: Modification and treatment","volume":"14","author":"Du","year":"2023","journal-title":"Front Immunol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113158","article-title":"The innate immune signaling pathways: Turning Rig-I sensor activation against cancer","volume":"12","author":"Iurescia","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.10.004","article-title":"Mir-545 inhibited pancreatic ductal adenocarcinoma growth by targeting Rig-I","volume":"588","author":"Song","year":"2014","journal-title":"FEBS Lett"},{"key":"B206","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1038\/s41467-022-34872-8","article-title":"Circcsnk1g3- and Circankib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment","volume":"13","author":"Piras","year":"2022","journal-title":"Nat Commun"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102230","article-title":"M6a methyltransferase Mettl3 promotes non-small-cell lung carcinoma progression by inhibiting the Rig-I-Mavs innate immune pathway","volume":"51","author":"Huang","year":"2025","journal-title":"Transl Oncol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005754","article-title":"Rig-I signaling is critical for efficient polyfunctional T cell responses during influenza virus infection","volume":"12","author":"Kandasamy","year":"2016","journal-title":"PloS Pathog"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.101973","article-title":"Ormdl3 restrains type I interferon signaling and anti-tumor immunity by promoting Rig-I degradation","volume":"13","author":"Zeng","year":"2025","journal-title":"Elife"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69339-7","article-title":"Cd38 degrades MAVS through mitophagy to inhibit type I interferon secretion in nasopharyngeal carcinoma cells and impairs CD8(+)T cell-mediated anti-tumor immunity","author":"Liang","year":"2026","journal-title":"Nat Commun"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2008.136","article-title":"The tumor suppressor CYLD is a negative regulator of Rig-I-mediated antiviral response","volume":"9","author":"Friedman","year":"2008","journal-title":"EMBO Rep"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3580","article-title":"Identification of a role for Trim29 in the control of innate immunity in the respiratory tract","volume":"17","author":"Xing","year":"2016","journal-title":"Nat Immunol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701569","article-title":"Trim29 negatively regulates the type I IFN production in response to RNA virus","volume":"201","author":"Xing","year":"2018","journal-title":"J Immunol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-024-44745-x","article-title":"Loss of Trim29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.01.011","article-title":"Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape","volume":"54","author":"Gu","year":"2023","journal-title":"J Adv Res"},{"key":"B216","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-023-04135-1","article-title":"ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma","volume":"21","author":"Qu","year":"2023","journal-title":"J Transl Med"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1434078","article-title":"Ginsenoside Rg3 targets glycosylation of PD-L1 to enhance anti-tumor immunity in non-small cell lung cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B218","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41598-024-84592-w","article-title":"Repeated ionizing radiation exposure induces Trip13 expression, conferring radioresistance in lung cancer cells","volume":"15","author":"Liu","year":"2025","journal-title":"Sci Rep"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2020.02.004","article-title":"The B7-H4 gene induces immune escape partly via upregulating the PD-1\/STAT3 pathway in non-small cell lung cancer","volume":"81","author":"Yuan","year":"2020","journal-title":"Hum Immunol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1887","article-title":"5'-Triphosphate-siRNA: Turning gene silencing and Rig-I activation against melanoma","volume":"14","author":"Poeck","year":"2008","journal-title":"Nat Med"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1172\/jci37155","article-title":"Proapoptotic signaling induced by Rig-I and Mda-5 results in type I interferon-independent apoptosis in human melanoma cells","volume":"119","author":"Besch","year":"2009","journal-title":"J Clin Invest"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8657","article-title":"cGAS in action: Expanding roles in immunity and inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190801","article-title":"Intratumoral delivery of Rig-I agonist SLR14 induces robust antitumor responses","volume":"216","author":"Jiang","year":"2019","journal-title":"J Exp Med"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B225","doi-asserted-by":"publisher","first-page":"357ra123","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci Transl Med"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1274478","article-title":"IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo","volume":"6","author":"Boieri","year":"2017","journal-title":"Oncoimmunology"},{"key":"B227","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.20082013","article-title":"IL-15 trans-presentation promotes human NK cell development and differentiation in vivo","volume":"206","author":"Huntington","year":"2009","journal-title":"J Exp Med"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.610789","article-title":"Transcription factors associated with IL-15 cytokine signaling during NK cell development","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31874","article-title":"Direct Rig-I activation in human NK cells induces TRAIL-dependent cytotoxicity toward autologous melanoma cells","volume":"144","author":"Da\u00dfler-Plenker","year":"2019","journal-title":"Int J Cancer"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00136-9","article-title":"Rig-I is an intracellular checkpoint that limits CD8(+) T-cell antitumor immunity","volume":"16","author":"Duan","year":"2024","journal-title":"EMBO Mol Med"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1172\/jci160790","article-title":"Intrinsic Rig-I restrains STAT5 activation to modulate antitumor activity of CD8+ T cells","volume":"133","author":"Jiang","year":"2023","journal-title":"J Clin Invest"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0190-0","article-title":"Neutrophil recruitment and activation are differentially dependent on MyD88\/TRIF and MAVS signaling during RSV infection","volume":"12","author":"Kirsebom","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00629","article-title":"The essential role of type I interferons in differentiation and activation of tumor-associated neutrophils","volume":"7","author":"Pylaeva","year":"2016","journal-title":"Front Immunol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-18-0730","article-title":"Therapeutically active Rig-I agonist induces immunogenic tumor cell killing in breast cancers","volume":"78","author":"Elion","year":"2018","journal-title":"Cancer Res"},{"key":"B235","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-020-00347-9","article-title":"Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transd Targ Ther"},{"key":"B236","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1038\/s41467-019-11250-5","article-title":"Rig-I-like receptors direct inflammatory macrophage polarization against West Nile virus infection","volume":"10","author":"Stone","year":"2019","journal-title":"Nat Commun"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S258450","article-title":"Rig-I promotes cell death in hepatocellular carcinoma by inducing M1 polarization of perineal macrophages through the Rig-I\/Mavs\/NF-\u03baB pathway","volume":"13","author":"Zhou","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1177624","article-title":"Rig-I agonist SLR10 promotes macrophage M1 polarization during influenza virus infection","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"B239","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1038\/s41467-022-31596-7","article-title":"Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9","volume":"13","author":"Fu","year":"2022","journal-title":"Nat Commun"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000099","article-title":"Rig-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages","volume":"4","author":"Wang","year":"2008","journal-title":"PloS Pathog"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01361-0","article-title":"The development of STING agonists and emerging results as a cancer immunotherapy","volume":"25","author":"Hines","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1485546","article-title":"Clinical applications of STING agonists in cancer immunotherapy: Current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1227833","article-title":"Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy","volume":"14","author":"Chakraborty","year":"2023","journal-title":"Front Immunol"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01405-9","article-title":"Exploiting Rig-I-like receptor pathway for cancer immunotherapy","volume":"16","author":"Jiang","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c20264","article-title":"Synergistic gene immunotherapy for lung cancer via targeted nanomedicine restoring genetic tumor suppression and activating STING pathway","volume":"20","author":"Chen","year":"2026","journal-title":"ACS Nano"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-0263","article-title":"A phase Ib open-label, multicenter study of inhaled DV281, a TLR9 agonist, in combination with nivolumab in patients with advanced or metastatic non-small cell lung cancer","volume":"27","author":"Garon","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.3096","article-title":"A phase I dose-escalation and expansion study of intratumoral CV8102 as single-agent or in combination with anti-PD-1 antibodies in patients with advanced solid tumors","volume":"38","author":"Eigentler","year":"2020","journal-title":"J Clin Oncol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2026.104646","article-title":"cGAS-STING pathway in lung cancer and emerging therapeutic approaches","volume":"31","author":"Joshi","year":"2026","journal-title":"Drug Discov Today"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.12263","article-title":"Therapeutic targeting of cGAS-STING pathway in lung cancer","volume":"49","author":"Wang","year":"2025","journal-title":"Cell Biol Int"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-2024-1097","article-title":"Towards the development of next-generation lung cancer immunotherapy","volume":"14","author":"Ichiki","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500296","article-title":"Sting agonists and how to reach their full potential in cancer immunotherapy","volume":"12","author":"Gehrcken","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B252","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"De Zuani","year":"2024","journal-title":"Nat Commun"},{"key":"B253","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-025-02287-w","article-title":"Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"24","author":"Cui","year":"2025","journal-title":"Mol Cancer"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00894-9","article-title":"Opportunities and challenges of targeting cgas\u2013sting in cancer","volume":"26","author":"Lu","year":"2026","journal-title":"Nat Rev Cancer"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.2521","article-title":"Safety and preliminary efficacy of eik1001 in combination with pembrolizumab in participants with advanced solid tumors","volume":"42","author":"Tolcher","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1842558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:30:04Z","timestamp":1778477404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1842558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":255,"alternative-id":["10.3389\/fimmu.2026.1842558"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1842558","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"article-number":"1842558"}}